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A B S T R A C T
Electrospinning was used as a novel technique for fabricating polymeric nanofibers of a serum
cholesterol lowering and poorly water-soluble plant sterol, β-sitosterol. Chitosan was used
as a stabilizer/carrier polymer. The mean diameters of nanofibers ranged from 150 nm to
218 nm. β-sitosterol was in an amorphous form and homogeneously dispersed in the
nanofibers. The β-sitosterol-loaded nanofibers were freely water-soluble and exhibited very
short lag-time in releasing the plant sterol. The dissolution was associated with an imme-
diate recrystallization of β-sitosterol in submicron level. In conclusion, electrospinning is a
promising future technology for the formulation of poorly water-soluble plant sterols.
© 2016 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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1. Introduction
Plant sterols, such as β-sitosterol and its saturated form
β-sitostanol (Fig. 1), have a serum cholesterol lowering effect
when administered orally [1–3]. They are generally applied in
phytosterol supplementation either as dissolved or dis-
persed in food (“functional food preparations”), or as
pharmaceutical oral preparations [4]. The main challenges as-
sociated with the oral administration of themost common plant
sterols (or phytosterols) are poor water solubility and high daily
doses (i.e., up to 3 g/day for β-sitosterol) [3,4]. Furthermore, their
solubility in edible fats and oils is very limited [5]. The physi-
cal state of the plant sterols has been shown to affect their
cholesterol absorption reducing effect [3,5,6].
To date, only few strategies have been proposed for im-
proving the oral administration and efficacy of plant sterols.
These have included a microcrystalline β-sitosterol suspension
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in oil [3], β-sitostanol oil suspension in capsules [7], pow-
dered plant sterol dissolved/dispersed in food (margarine) [8],
esterification of plant sterols [5], andmore recently plant sterols
combined with, or esterified to, fish-oil fatty acids [9]. Each strat-
egy has some advantages in clinical effectiveness, but there
is still no ideal oral preparation for plant sterols. In spite of
these novel formulation approaches, the oral administration
of the plant sterols in the management of hypercholesterol-
emia has been questioned [10].
Nanofibers hold today great promises for a wide range of
biomedical and pharmaceutical applications, including tissue
engineering, drug delivery systems and solubility/stability en-
hancement [11–13]. Electrospinning (ES) is an effective and
up-scalable continuous method to fabricate nanofibers with
a diameter from a few tenths of nanometers to several mi-
crometers, and a large surface area [12]. Recently, this technique
has been used to fabricate high-energy amorphous solid dis-
persions (SDs) of poorly water-soluble drugs [14–16]. It is
generally known that the amorphous form of a drug has an
enhanced dissolution and bioavailability compared to the
crystalline counterpart, but the amorphous form is physi-
cally very unstable. We hypothesize that the application of
ES and hydrophilic carrier polymer(s) could be an interesting
approach for stabilizing plant sterols in an amorphous
form, and consequently, improving their dissolution and
bioavailability. To the best of our knowledge, ES or any other
related processes have not been applied to formulate plant
sterols into nanofibers.
The present work aims to investigate ES as a novel tech-
nique for preparing amorphous polymeric nanofibers of poorly
water-soluble β-sitosterol and a hydrophilic polymer (chitosan).
In this proof-of-the-concept study, the main hypothesis was
that the electrospun nanofibers could improve the solubility
and dissolution behavior of β-sitosterol by affecting the solid
state of the active substance. Special attention was paid to the
effects of a carrier polymer and solvent system on the solid-
state properties, wetting and early-stage dissolution of the
nanofibers.
2. Materials and methods
2.1. Materials
β-sitosterol (Calbiochem®, Merck Millipore, Merck KGaA, Darm-
stadt, Germany) contained 75.5% β-sitosterol, β-sitostanol (13%),
campesterol (8.4%), campestanol (1.3%), and contaminants (1.8%)
as related substances. Chitosan Ch 90/160 (Primex BioChemicals
AS, Haugesund, Norway) was used as a stabilizer and carrier
polymer in nanofibers.The solvents tested for ES were ethanol
(96% w/V) (Lach-Ner s.r.o., Brno, Czech Republic), acetic acid
(Sigma-Aldrich Chemie GmbH,Munich Germany), trifluoroacetic
acid (TFA, Riedel-de Haën®, Seelze, Germany) and 1,1,1,3,3,3-
hexa-fluoro-2-propanol (HFIP, Sigma-Aldrich BVBA Diegem,
Belgium).
2.2. Selection of solvent system for electrospinning
The solubility/miscibility of crystalline β-sitosterol and the
carrier polymer (chitosan) in different solvent systems was
tested based on the visual inspection and based on the values
obtained from the literature. A total of 350.0 mg (175 mg
β-sitosterol + 175 mg chitosan) of solid material was placed into
a glass vial and the organic solvent (5.0 ml) was added bymanu-
ally stirring with a glass rod. The total concentration (w/V) of
solids was 7.0% (w/V), and the ratio of β-sitosterol and chitosan
was 1:1. Alternatively, the corresponding binary solvent mix-
tures (2.5 + 2.5 ml or 1.67 + 3.33 ml) were added by stirring with
a glass rod. The appearance of solution/dispersion was visu-
ally inspected within regular intervals for subsequent 24 hours.
2.3. Electrospinning of the nanofibers
The β-sitosterol-chitosan SD nanofibers were prepared using
an ESR200RD robotized ES system (NanoNC Co. Ltd., Seoul, Re-
public of Korea).A schematic diagram of the ES process is shown
in Fig. 2.The ES set-up consisted of a high-voltage power supply
(Model HV30; maximum voltage 30 kV), a robotic-controlled au-
tomatic syringe pump (type X1EA, min. 0.01 μm/min, 10 ml
installation), a plastic Norm-Ject® syringe (Henke Sass Wolf,
Tuttlingen, Germany) with a needle size of 23G (inner diam-
eter 0.34mm, outer diameter 0.64mm), and a grounded collector
plate.The flow rate of the solution was 0.5 ml/h and the voltage
applied was 10–12 kV.The distance between the spinneret and
the fiber collector was 10 cm.All experiments were carried out
at room temperature (22 ± 2 °C) and 18–25% RH.
The ratio of β-sitosterol and chitosan used in the nanofibers
was 1:1 (w/w), and the total solid concentration in the organic
solvent system was 7.0% (w/w). The final theoretical concen-
tration of β-sitosterol in the electrospun nanofibers at a dried
state was 50% (w/w).
2.4. Characterization of the nanofibers
The size (diameter) and morphology of the nanofibers were in-
vestigated with a scanning electron microscope (SEM, Zeiss
EVO® 15 MA, Germany). All samples were mounted on alumi-
num stubs with a double-sided tape and then coated (Agar
Sputter Coater, Agar Scientific, Stansted, United Kingdom) with
Fig. 1 – Molecular structure of (A) cholesterol, (B) β-sitosterol
and (C) β-sitostanol.
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a 3-nm gold layer (100 sec/25 mA) in an argon atmosphere prior
to microscopy.The ImageJ software (Version 1.49) was used to
measure the nanofiber size distribution.
2.5. Solid-state properties analyses
The solid-state properties of the starting materials and the
electrospun nanofibers were studied by X-ray powder diffrac-
tion (XRPD, D8Advance, Bruker AXS GmbH, Germany).The XRPD
experiments were carried out in a symmetrical reflection mode
(Bragg-Brentano geometry) with CuKα radiation (1.54 Å). The
scattered intensities were measured with a LynxEye one-
dimensional detector with 165 channels.The angular range was
from 3° 2θ to 70° 2θ with steps of 0.0185° 2θ. The total mea-
suring time was 83 seconds per step.The operating current and
voltage were 40 mA and 40 kV, respectively.
Raman spectra were collected using a Raman spectrom-
eter (B&W TEK, Inc., Newark, DE, USA) equipped with a fiber
optic probe.The laser source was a 300-mW diode laser system
which is operating at 785 nm.
Differential scanning calorimetry (DSC, DSC4000, PerkinElmer
Ltd., Waltham, Massachusetts, USA) was used for investigat-
ing the thermal behavior of both the pure materials and the
nanofibrous samples.
2.6. Wetting and dissolution measurements
The wetting and dissolution properties of the SD nanofibers
were monitored in situ by using an optical microscope (mag-
nification 50×) (Leica DMLB, Germany) equipped with a digital
camera (Canon PowerShot S50, Canon, Japan). A nanofibrous
sample was placed onto the microscope glass plate, and sub-
sequently 1–2 standard drops of aqueous solution were carefully
added onto the samples at room temperature (22 ± 2 °C). The
solutions studied were (1) an aqueous buffer solution pH 1.2
(KCl/HCl), (2) phosphate buffer pH 7.2, and (3) purified water.
Micrographs were taken in regular intervals every 2 seconds,
and for some experiments 10 s video clips were recorded.
3. Results and discussion
3.1. Electrospinning of β-sitosterol loaded nanofibers
So far, there are no studies in the literature describing the for-
mulation of plant sterols into nanofibers in order to improve
their physical solid-state stability, dissolution and bioavailability.
This is obviously due to the challenging physicochemical prop-
erties of such plant sterols and their derivatives, including
crystallinity (and polymorphism), poor water solubility, limited
solubility in oils and fats, and rather large doses needed for
effective lowering of the serum cholesterol levels. The major
ES process-related challenge is also to find a proper carrier
polymer and solvent system.
Table 1 presents the results of the solubility/miscibility of
β-sitosterol and chitosan in purified water and different organic
solvents/solvent systems. The test was based on visual in-
spection. Both β-sitosterol and chitosan were practically
insoluble in purified water, but they dissolved in HFIP andTFA
and in their mixtures. Consequently, non-aqueous and readily
evaporating HFIP and TFA were selected for further ES experi-
ments with β-sitosterol and chitosan.The 1/1TFA/HFIP mixture
was selected, since HFIP is more readily evaporating solvent,
which is an advantage in ES. In addition, by increasing the
amount of TFA (the 2/1 mixture), the viscosity of the solvent
system decreased and the formation of nanofibers was pre-
vented (only dots were obtained). Regarding the use of TFA/
acetic acid, the present solvent systemwas not electrospinnable,
even though the viscosity of the mixture was at a proper level
(both TFA and acetic acid are not readily evaporating). The for-
mation of nanofibers was not successful, resulting in very brittle
nanofibers.
Fig. 2 – Schematic diagram of the electrospinning set-up.
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ES of β-sitosterol-loaded chitosan nanofibers using TFA and
HFIP as solvents was performed successfully without any sig-
nificant drawbacks. The mean diameters measured by SEM of
the electrospun SD nanofibers were 217.6 ± 98.6 nm (TFA) and
149.7 ± 69.1 nm (TFA + HFIP) depending on the solvent system
used (Figs. 3 and 4). Individual fiber diameters ranged from
50 nm to 750 nm. It is evident that changing the solvent system
from a single solvent (TFA) to a binary solvent mixture
(TFA + HFIP) influences the viscosity of the jet, thus affecting
the nanofibers’ diameter (see also Table 1). According to Wil-
liams et al. [17], increasing the viscosity of the solvent system
will allow the electrospun jet to withstand greater Coulom-
bic repulsions, giving generally a large fiber diameter. The
Coulombic repulsion forces are formed between the charges
on the jet surface, and once these repulsive forces overcome
the surface tension of the liquid a jet is ejected from the apex
of the cone (the cone-jet) [17,18].The Coulombic repulsion forces
are directly proportional to the applied voltage and reduce as
the applied voltage on the emitter needle decreases [19].
The solvent system affected also the distribution of fiber
diameter and the surfacemorphologies of the nanofibers (Figs. 3
and 4). Interestingly, the SEM images displayed individual
nanoparticles (with an average diameter of ~ 100–200 nm) em-
bedded in the network of the nanofibers. This suggests
concomitant ES and electrospraying, resulting in the forma-
tion of nanoparticles in the nanofibrous network as “by
products.”This phenomenon can be controlled by varying the
electrospun solution (e.g. polymer concentration) or process-
ing (voltage, collection distance parameters). Since the present
study is more like a proof-of-the-concept work, the experi-
mental parameters of ES were not fully optimized. However,
this would be an important topic area for future studies. As
seen in Fig. 3B, some individual spherical beads (“bulbs”) were
observed in the nanomats electrospun with the binary solvent
system TFA + HFIP. According to the literature, the beads are
related to the instability of the jet of polymer solution, and they
are generally formed if the surface tension of a solution is high
or if the viscosity of a solution is low [17,20,21]. The solution
surface tension and viscosity are mainly dependent on the
solvent system and polymer concentration, respectively. More-
over, the net charge density carried by the jet of ES enhances
Table 1 – Solubility/miscibility of crystalline β-sitosterol and chitosan in different solvent systems.
Exp. Material Solvent Concentration
(w/w)
Comments
1 β-sitosterol Ethanol 3.5% White dispersion with sedimentation, not viscous
2 β-sitosterol HFIP 3.5% Violet, clear solution, not viscous
3 β-sitosterol TFA 3.5% Dark, brownish-purple dispersion, not viscous
4 Chitosan TFA 3.5% Clear, yellow, viscous solution
5 Chitosan Acetic acid 3.5% White-yellow (creamy), cloudy, low viscous dispersion
6 β-sitosterol/chitosan 1:1 (w/w) Ethanol/acetic acid 3.5% Creamy, white dispersion with yellow sedimentation,
low viscosity
7 β-sitosterol/chitosan 1:1 (w/w) HFIP/acetic acid 3.5% Yellowish-white gel, high viscosity dispersion
8 β-sitosterol/chitosan 1:1 (w/w) TFA/acetic acid 3.5% Dark brown, clear, high viscous solution
9 β-sitosterol/chitosan 1:1 (w/w) TFA 3.5% Brownish-purple, high viscous solution
10 β-sitosterol/chitosan 1:1 (w/w) TFA/ethanol 3.5% Yellowish-white dispersion (with sedimentation), low viscosity
11 β-sitosterol/chitosan 1:1 (w/w) TFA/HFIP 2:1 (w/w) 3.5% Dark purple, clear solution, high viscosity
12 β-sitosterol/chitosan 1:1 (w/w) TFA/HFIP 1:1 (w/w) 3.5% Dark purple, clear solution, high viscosity
HFIP = hexafluoroisopropanol; TFA = trifluoroacetic acid.
Fig. 3 – Scanning electron microscopy (SEM) micrographs of
the electrospun chitosan nanofibers loaded with
β-sitosterol. Key: (A) Single solvent system (TFA);
(B) binary solvent system (TFA + HFIP). Magnification
20,000×.
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the formation of the beaded nanofibers [21]. In conclusion, the
formation of nanoparticles and individual larger beads (“bulbs”)
as “by products” in the nanofibrous network in our study is most
likely due to the following two reasons: relatively low viscos-
ity of the polymer solution and voltage applied in the non-
optimized process.
3.2. Physical solid-state properties of the nanofibers
According to the literature, free crystalline β-sitosterol exists
in three different solid state forms with different water con-
tents: anhydrated, hemihydrated and monohydrated crystals
[3,22]. In the present study, β-sitosterol was originally in crys-
talline anhydrate form as verified by XRPD. As shown in Fig. 5,
the characteristic major peaks for the crystalline anhydrate form
of β-sitosterol were observed at the diffraction angles 2θ of 7.1°,
11.9°, 12.7°, 15.0°, 18.3°, and 19.1°. In our study, most likely the
controlled storage conditions enabled the β-sitosterol to remain
in an anhydrate form, and consequently the plant sterol did
not undergo any solid-state changes to hemihydrate or mono-
hydrate forms during a storage period prior to ES.
The XRPD patterns of the electrospun nanofibers loaded with
β-sitosterol and chitosan at a weight ratio of 1:1 (TFA or the
TFA/HFIP 1:1 mixture as solvent systems) showed an amor-
phous halo and absence of crystallinity (Fig. 5).The characteristic
XRPD reflections of β-sitosterol anhydrate crystal form were
not observed anymore in the XRPD patterns of the electrospun
nanofibers. According to the literature, chitosan appears in par-
tially crystalline solid phase with the characteristic broad peaks
at diffraction angles 2θ of 9–10° and 19–20° in its XRPD pattern
[23,24]. As seen in Fig. 5, the physical form of the chitosan used
in the present study was in good accordance with that re-
ported in the literature. As expected, the characteristic broad
diffraction reflections of chitosan were not observed anymore
in the XRPD patterns of the electrospun nanofibers (Fig. 5).The
crystallographic properties of natural chitosan, however, can
depend on several parameters, including its origin, molecu-
lar weight, deacetylation procedure and treatments used to
condition the material (dissolving, precipitation, drying) [23].
It seems that dissolving chitosan to the organic solvents (the
TFA/HFIP mixture is acidic) and the rapid evaporation of solvent
in the ES process affected chitosan chain packing and de-
creased crystallinity. Hence, the present results suggest that
ES with chitosan can be used for the amorphization of a poorly
water-soluble crystalline β-sitosterol and also for fabricating
amorphous solid dispersions (polymeric nanofiber matrices)
of this plant sterol.
As seen in Fig. 6, the electrospun chitosan nanofibers con-
taining β-sitosterol did not show the characteristic melting
endotherm of crystalline β-sitosterol anhydrate in the DSC ther-
mogram, confirming the presence of amorphous drug.
Christiansen [3] reported that crystalline β-sitosterol anhydrate
exhibits the melting endotherm at 133–138 °C (peak tempera-
ture). In our study, however, β-sitosterol powder exhibited a
lower melting endotherm at 115–120 °C (peak temperature)
(Fig. 6A).This difference in melting temperatures is most likely
due to the different measurement settings (open vs closed pans,
heating rate) as well as the fact that the β-sitosterol used in
this study contained also other constituents, β-sitostanol (13%),
campesterol (8.4%), campestanol (1.3%), and contaminants
(1.8%), as related substances. In addition, a wide endother-
mic peak belowmelting could suggest a partial phase transition
of β-sitosterol from anhydrate to monohydrate form (Fig. 6A).
Chitosan thermal behavior (shown in Fig. 6B) was in good agree-
ment with that reported in the literature [25].
Fig. 4 – SEM fiber diameter size distributions of the
electrospun chitosan nanofibers loaded with β-sitosterol
(BSS) and the electrospun with a single solvent system
(TFA) or binary solvent system (TFA + HFIP).
Fig. 5 – XRPD patterns for a commercial β-sitosterol powder
(black line), chitosan (purple line) and electrospun
nanofibers containing β-sitosterol and chitosan (1:1). TFA
(green line) and the TFA/HFIP mixture 1:1 (blue line) were
used as solvent systems for preparing the nanofibers.
Theoretically calculated XRPD patterns of the three
different crystal forms of β-sitosterol at room temperature
are shown as references (obtained from the Cambridge
Structural Database): anhydrate (LOFFET) (black line),
hemihydrate (JOGMUP) (red line), monohydrate (TEXQOC)
(blue line). Dotted line shows the peak positions of the
characteristic β-sitosterol anhydrate XRPD reflections.
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3.3. Wetting and dissolution of the nanofibers
A prerequisite of cholesterol-lowering effect of oral plant sterols
is that the sterol(s) have a rapid dissolution in intestinal fluids
and bile, and that the uniformmixture of finely dispersed plant
sterol(s) with the cholesterol containing food mass is simul-
taneously directed in the intestine [3].This poses overwhelming
challenges for the pharmaceutical formulation, and emerges
the need for nanotechnology approaches to solve the problem.
According to the literature, the cholesterol absorption re-
ducing effect of oral β-sitosterol and its saturated form,
β-sitostanol, is dependent on their physical solid-state form,
solubility and formulation (final dosage form) [3,6]. In our study,
β-sitosterol was homogeneously and finely distributed in the
nanofibers after fabrication (as shown in Fig. 3). Based on the
in situ dissolution monitoring, the electrospun β-sitosterol-
loaded nanofibers were freely water-soluble and exhibited very
short lag-time in releasing the active substance (Fig. 7).
β-sitosterol, however, tended to immediately recrystallize (or
form submicron particles), when released from the poly-
meric nanofibers.The tiny crystals/particles of β-sitosterol were
clearly visible in the vicinity of the nanofibers immediately after
the addition of purified water or buffer solutions (Fig. 7). No
significant differences were observed between the three dif-
ferent aqueous media studied in dissolving β-sitosterol-
loaded nanofibers. As the composite nanofibers were further
dissolved, the β-sitosterol crystals/particles still remained for
3–5 minutes in the buffer solution before they dissolved as well.
This suggests that ES can be used for fabricating the compos-
ite nanofibers intended for templates of plant sterols (β-
sitosterol), which allow the spontaneous in situ formation of
submicron β-sitosterol particles when the nanofibers are added
to water. The present approach could open a new alternative
to formulate oral plant sterols for cholesterol lowering. In the
literature, nanofibers have been successfully used for formu-
lating the templates for self-assembled systems [26]. In addition,
the utilization of advanced ES technologies (e.g., by prepar-
ing multi-active composites, ES printing for controlled
patterning and porous capsules) could provide promising mul-
tiple platforms for plant sterols [27–29].
4. Conclusion
The present proof-of-the-concept study shows that
electrospinning (ES) is a promising future technology for the
formulation of poorly water-soluble crystalline plant sterols.
ES is a rapid, continuous and up-scalable process, which pro-
vides non-destructive conditions for the formulation
(vitrification) of plant sterols to amorphous solid dosage forms.
Application of ES and a cationic carrier biopolymer (chitosan)
Fig. 6 – Differential scanning calorimetry (DSC)
thermograms. Key: (A) β-sitosterol (black line), (B) chitosan
(purple line), and (C) the electrospun nanofibers containing
β-sitosterol and chitosan (1:1) (blue line). The TFA/HFIP
mixture (1:1) was used as solvent systems for preparing
the nanofibers.
Fig. 7 – In-situ optical microscopy of the wetting and
dissolution behavior of the nanofibers. The representative
micrographs show chitosan-β-sitosterol nanofibers in
contact with a buffer solution at pH 1.2. Key: (A)
Immediately after wetting, β-sitosterol tended to
recrystallize out from the nanofibers. (B) As the nanofibers
were further dissolved, the β-sitosterol crystals still
remained for 3–5 minutes in the buffer solution before they
dissolved as well. Blue arrows indicate the tiny crystals of
β-sitosterol in the vicinity of the nanofibers.
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in highly acidic organic solvents could be an interesting ap-
proach for the formulation of poorly water-soluble plant sterols
(such as β-sitosterol) in amorphous solid dispersions, and hence
to improve their dissolution and cholesterol lowering effects
via oral route. Using ES for fabricating nanofibrous templates
of plant sterols (β-sitosterol), and consequently, allowing the
spontaneous in situ formation of submicron β-sitosterol par-
ticles, can open a new avenue to formulate oral plant sterols.
A major challenge, however, still remains in the solid-state sta-
bilization (polymorphic changes) of a plant sterol in a
nanofibrous solid dispersion matrix.
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